Ovation Science Inc.
OVATF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $113 | $62 | $138 | $225 |
| % Growth | 82.8% | -55.2% | -38.6% | – |
| Cost of Goods Sold | $27 | $8 | $3 | $37 |
| Gross Profit | $86 | $54 | $135 | $188 |
| % Margin | 75.7% | 87.4% | 97.8% | 83.6% |
| R&D Expenses | $13 | $9 | $65 | $83 |
| G&A Expenses | $250 | $458 | $428 | $892 |
| SG&A Expenses | $254 | $473 | $448 | $926 |
| Sales & Mktg Exp. | $4 | $14 | $20 | $34 |
| Other Operating Expenses | $298 | $268 | $415 | $8 |
| Operating Expenses | $565 | $749 | $928 | $1,017 |
| Operating Income | -$479 | -$695 | -$739 | -$1,516 |
| % Margin | -423.1% | -1,122.4% | -534.7% | -674.1% |
| Other Income/Exp. Net | $23 | -$118 | -$55 | -$877 |
| Pre-Tax Income | -$456 | -$813 | -$794 | -$2,394 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$456 | -$813 | -$794 | -$2,394 |
| % Margin | -402.9% | -1,312.9% | -574.8% | -1,064.1% |
| EPS | -0.013 | -0.027 | -0.027 | -0.082 |
| % Growth | 51.5% | 0.7% | 66.9% | – |
| EPS Diluted | -0.013 | -0.027 | -0.027 | -0.082 |
| Weighted Avg Shares Out | 34,983 | 30,321 | 29,375 | 29,375 |
| Weighted Avg Shares Out Dil | 34,983 | 30,321 | 29,375 | 29,375 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $5 |
| Interest Expense | $50 | $31 | $1 | $0 |
| Depreciation & Amortization | $2 | $3 | $7 | $8 |
| EBITDA | -$404 | -$779 | -$787 | -$1,516 |
| % Margin | -357% | -1,257.5% | -569.5% | -674.1% |